GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

Trending Topics in Gastroenterology

Explore current gastroenterology questions, clinical answers, and emerging research by topic.

01

Olomorasib Receives FDA Breakthrough Therapy Designation in KRAS G12C–Mutant Pancreatic Cancer: FDA / Oncology Update | August 2026

Introduction: KRAS mutations drive the vast majority of pancreatic cancers, but KRAS G12C represents only about 1–2% of cases. This small molecular subgroup is increasingly actionable. The FDA...

02

A Simple Blood-Based Biomarker (SIRI) Predicts Outcomes in Metastatic Pancreatic Cancer: Pancreatology | August 2026

Introduction: Systemic inflammation plays a major role in pancreatic ductal adenocarcinoma (PDAC), contributing to tumor progression, cachexia, and treatment resistance. The Systemic Inflammation Response Index (SIRI) combines neutrophil,...

03

Higher Dietary Vitamin B6 Intake Is Associated With Lower Gallstone Prevalence: Medicine | August 2026

Introduction: Vitamin B6 participates in cholesterol metabolism, oxidative stress regulation, and inflammatory pathways that may influence gallstone formation. This population-based analysis examined whether dietary vitamin B6 intake is...

04

Fatty Pancreas Predicts Diabetes, Kidney Disease, and Cardiovascular Risk: UEG Journal | July 2026

Introduction: Fatty pancreas is increasingly recognized as an ectopic fat depot with metabolic consequences, but its clinical significance has been difficult to define because previous studies used inconsistent...

05

Nivolumab–Ipilimumab Shows Promising Activity in Gallbladder Cancer: Clinical Cancer Research | August 2026

Introduction: Dual immune checkpoint blockade with nivolumab plus ipilimumab has shown activity across several malignancies, but its role in advanced biliary tract cancer remains uncertain. The Phase II...

06

Targeting Cholesterol Metabolism is A New Strategy to Overcome Chemotherapy Resistance in Pancreatic Cancer: National Cancer Institute Research | August 2026

Introduction: Pancreatic ductal adenocarcinoma (PDAC) frequently develops resistance to chemotherapy through metabolic adaptations that enhance tumor survival. New research from the University of Oklahoma is investigating whether pancreatic...

07

BiliSeq DNA/RNA Next-Generation Sequencing Improves the Diagnosis of Neoplastic Bile Duct Strictures: Gastroenterology | August 2026

Introduction: Distinguishing benign from malignant biliary strictures remains one of the greatest challenges in pancreatobiliary endoscopy. Although ERCP brush cytology and biopsy have excellent specificity, their sensitivity is...

08

Engineered Microbial Lipase: GHE | July 2026

Introduction: Pancreatic enzyme replacement therapy (PERT) is the standard treatment for exocrine pancreatic insufficiency (EPI) but is currently derived exclusively from porcine pancreatic extracts, requiring multiple capsules and...

09

Deep Learning for Automated Pancreatic Cancer Segmentation: NPJ Precision Oncology | July 2026

Introduction: Accurate tumour segmentation is fundamental for precision oncology, enabling objective assessment of tumour burden, treatment response, and radiomics analysis. This study developed and validated an anatomically constrained...

10

When Can We Safely Stop Follow-up IPMN Surveillance: Annals of Surgery | July 2026

Introduction: The widespread detection of intraductal papillary mucinous neoplasms (IPMNs) has substantially increased surveillance programs, although only a small proportion progress to pancreatic cancer. This study evaluated the...

Previous
1234567
Next
GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer